AbbVie M16-904

Enroll Now

Type of Study:

Interventional

Title of Study:

Leuprolide acetate

Short Title:

AbbVie M16-904

Study Length: up to 3 years

Target Age/Sex: 5– 10 years of age, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures and compensation for time

Link: clinicaltrials.gov